Figure 2
CD27+ B cells are decreased in X-HIgM. PBMCs from patients with X-HIgM and NDs were stained with CD19, IgD, and CD27 fluorochrome-conjugated antibodies and analyzed by flow cytometry using CELLQuest software. The percentage of naive (CD19+IgD+CD27−), preswitch (CD19+IgD+CD27+), and postswitch (CD19+IgD−CD27+) cells represent the data analyzed from four 7- to 13-year-old patients with X-HIgM and 4 NDs. *Significant (P < .001) difference in the percentage of cells between ND and X-HIgM.

CD27+ B cells are decreased in X-HIgM. PBMCs from patients with X-HIgM and NDs were stained with CD19, IgD, and CD27 fluorochrome-conjugated antibodies and analyzed by flow cytometry using CELLQuest software. The percentage of naive (CD19+IgD+CD27), preswitch (CD19+IgD+CD27+), and postswitch (CD19+IgDCD27+) cells represent the data analyzed from four 7- to 13-year-old patients with X-HIgM and 4 NDs. *Significant (P < .001) difference in the percentage of cells between ND and X-HIgM.

Close Modal

or Create an Account

Close Modal
Close Modal